News brief­ing: Gilead part­ner Gala­pa­gos sells off CRO for $37M; Polyphor bags $3.3M from CF Foun­da­tion

Close Gilead al­ly Gala­pa­gos is sell­ing off one of its con­tract re­search or­ga­ni­za­tions to a Pol­ish phar­ma com­pa­ny.

Gala­pa­gos has

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.